Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lenox Pasifik Investama Tbk. (LPPS) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance

Lenox Pasifik Investama Tbk.Trade
Tempo Scan Pacific Tbk.Trade

Price performance (Past 24H)

Key statistics

Lenox Pasifik Investama Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Lenox Pasifik Investama Tbk. trades at Rp79 (market cap 181.18B, 76.86M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,590 (market cap 11.36T, 1.77M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 62.7× Lenox Pasifik Investama Tbk.'s market cap, and Lenox Pasifik Investama Tbk. is more actively traded (76.86M versus 1.77M). Which is the better fit depends on your goals.

LPPSTSPC
Market Cap
181.18B11.36T
Volume
76.86M1.77M
Lot
768.6K17.71K
Turnover
6.58B4.61B
Average Price
85.592,603.9
Value
6.58B4.61B
Indicative Equilibrium Price
792,590
Indicative Equilibrium Volume
9.22K300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LPPS
View details
TSPC
View details

About Lenox Pasifik Investama Tbk.

PT Lippo Securities Tbk (the Parent Company) was established on June 20, 1989 based on notarial deed No.514 of Misahardi Wilamarta, S.H. The deed of establishment was approved by the Ministry of Justice of the Republic of Indonesia (MOJ) in its decision letter No.C2-6029.HT.01.01TH.89 dated July 6, 1989, and was published in the State of Gazette No.80 Supplement No. 3904 dated October 5, 1990. Its articles of association has been amended several times, most recently by notarial deed No.113 of Ny. Poerbaningsih Asi Warsito, S.H., dated July 30,1999, concerning among others, the adjustments to effect the Regulation No.IX.D.I. On December 20, 1999, the Parent Company submitted a letter to the Chief of the Capital Market Supervisory Board requesting for the revocation of its business license as broker, in connection with the merger of its brokering activities with PT Ciptadana Sekuritas, a subsidiary. This request was approved by the Chief of the Capital Market Supervisory Board based on its decision letter No. 01/PM/2000 dated January 5, 2000.In view of the foregoing, PT Bursa Efek Jakarta in its letter No.S.024/BEJ.ANG/01-2000 dated January 12, 2000 and PT Bursa Efek Surabaya in its letter No. T1-003/AGT/BES/I/2000 dated January 1, 2000, cancelled their Approval Letter on Stock Exchange Membership (Surat Persetujuan Anggota Bursa) issued to the Parent Company effective January 13, 2000 and January 4, 2000, respectively. Accordingly, the Parent Company is required to sell its investments in shares of stock of PT Bursa Efek Jakarta and PT Bursa Efek Surabaya.

Read more on LPPS

About Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Read more on TSPC